Mark Stenhouse - Director at Phathom Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Stenhouse since 11/12/2023

Holdings reported by Mark Stenhouse for Phathom Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 19.5K $178K $9.11 May 23, 2024 Direct
Stock Option (Right to Buy) 17.5K May 23, 2024 Direct Common Stock

Transactions reported by Mark Stenhouse for Phathom Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.